Form 8-K - Current report:
SEC Accession No. 0000950123-20-006441
Filing Date
2020-06-29
Accepted
2020-06-29 08:21:15
Documents
2
Period of Report
2020-06-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d944373d8k.htm 8-K 16754
2 EX-99.1 d944373dex991.htm EX-99.1 59459
  Complete submission text file 0000950123-20-006441.txt   77425
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38906 | Film No.: 20995972
SIC: 2836 Biological Products, (No Diagnostic Substances)